Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12864
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJackson, Ben
dc.contributor.authorJohnston, Colin Ien
dc.date.accessioned2015-05-16T02:36:46Z
dc.date.available2015-05-16T02:36:46Z
dc.date.issued1988-06-01en
dc.identifier.citationJournal of Hypertension; 6(6): 495-501en
dc.identifier.govdoc2842393en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12864en
dc.description.abstractIn order to establish if pharmacological treatment of systemic hypertension modifies the course of progressive renal failure, we studied the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist, on the renal structure and function in the remnant kidney model of chronic renal failure in the rat. Progressive renal failure was induced in adult female Sprague Dawley rats (SDR) by surgical removal of the right kidney, and segmental infarction of seven-eighths of the left kidney. Following subtotal nephrectomy, plasma creatinine rose from 65 +/- 16 mumol/l to 173 +/- 19 mumol/l (P less than 0.001) over a period of 6 weeks, systolic blood pressure (SBP) rose from 121 +/- 2 mmHg to 176 +/- 7 mmHg (P less than 0.001) and urinary protein excretion from 0.6 +/- 0.2 to 84 +/- 22 mg/24 h (P less than 0.001). Glomerular mesangial expansion was present after 2 weeks, then progressed, in association with the development of glomerular sclerosis, which became prominent after 6 weeks. Rats were treated with enalapril (5 mg/kg per day) or felodipine (30 mg/kg per day) from 1 week after subtotal nephrectomy, and their course compared with that of untreated rats. Systemic SBP decreased to a similar degree by both drug treatments. Six weeks after surgery, plasma creatinine concentration was lower in the enalapril-treated group (110 +/- 8 mumol/l, P less than 0.05) than in the felodipine-treated group (153 +/- 23 mumol/l). The latter group showed similar plasma creatinine concentrations to those of the untreated rats (173 +/- 19 mumol/l).(ABSTRACT TRUNCATED AT 250 WORDS)en
dc.language.isoenen
dc.subject.otherAngiotensin-Converting Enzyme Inhibitors.therapeutic useen
dc.subject.otherAnimalsen
dc.subject.otherBlood Pressure.drug effectsen
dc.subject.otherCalcium Channel Blockers.therapeutic useen
dc.subject.otherEnalapril.therapeutic useen
dc.subject.otherFelodipineen
dc.subject.otherFemaleen
dc.subject.otherHypertension, Renovascular.drug therapyen
dc.subject.otherKidney Failure, Chronic.drug therapy.etiologyen
dc.subject.otherNitrendipine.analogs & derivatives.therapeutic useen
dc.subject.otherRatsen
dc.subject.otherRats, Inbred Strainsen
dc.titleThe contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Hypertensionen
dc.identifier.affiliationMelbourne University Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australiaen
dc.description.pages495-501en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/2842393en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

2
checked on Feb 5, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.